OPTFSNA
TOVX icon

Old Point Trust & Financial Services N A’s Theriva Biologics TOVX Stock Holding History

Old Point Trust & Financial Services N A’s Portfolio TOVX Stock Details TOVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-4
Closed -$24 – 352
2024
Q2 		$24 Hold
4
– – ﹤0.01% 347
2024
Q1 		$47 Buy
+4
New +$47 ﹤0.01% 546

Other funds holding TOVX

HCM
Heights Capital Management San Francisco, California $359M AUM 7.93% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Old Point Trust & Financial Services N A's TOVX Position: Q3 2024 in Review

Old Point Trust & Financial Services N A sold out of Theriva Biologics (TOVX) in Q3 2024, closing a stake of 4 shares — an estimated $24 sold.

Old Point Trust & Financial Services N A first reported a position in TOVX in Q1 2024 and held it in 2 quarters. The position peaked at $47 in Q1 2024. 18 funds tracked by Wall St. Rank hold TOVX as of Q3 2024.

  • Old Point Trust & Financial Services N A reported no remaining Theriva Biologics position as of Q3 2024 after selling out during the quarter.
  • Old Point Trust & Financial Services N A sold 4 Theriva Biologics shares in Q3 2024, an estimated $24.
  • Old Point Trust & Financial Services N A first reported a position in Theriva Biologics in Q1 2024 and held it in 2 quarters.
  • Old Point Trust & Financial Services N A's Theriva Biologics position peaked at $47 in Q1 2024.
  • 18 funds tracked by Wall St. Rank held Theriva Biologics as of Q3 2024.

Based on Old Point Trust & Financial Services N A's 13F filing for Q3 2024, filed 8 Nov 2024.